Antares Pharma, Inc. (ATRS)

Retained Earnings

-$178.66M

Quarterly · Period ending: · USD

ATRS logo

ATRS Retained Earnings

Latest reported-$178.66M
ATRS Quarterly Retained Earnings (-$10.50M → -$178.66M)
High-resolution chart · PNG

ATRS retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-178,658,000
-176,337,000
-209,020,000
-214,413,000
-218,833,000
-222,626,000
-274,012,000
-279,008,000
-281,183,000
-278,827,000
-283,406,000
-284,449,000
-282,223,000
-276,800,000
-282,934,000
-280,998,000
-276,478,000
-270,285,000
-266,570,874
-261,118,353
-258,278,409
-253,445,306
-248,945,058
-242,824,075
-236,762,612
-229,106,502
-222,480,017
-216,741,976
-215,235,330
-208,447,656
-198,374,712
-191,188,271
-182,090,546
-173,295,941
-167,660,826
-161,300,869
-156,197,613
-152,789,165
-147,777,420
-144,243,181
-141,436,109
-141,361,715
-141,207,784
-139,908,525
-138,354,428
-136,973,795
-135,675,194
-134,043,794
-132,491,540
-130,882,597
-128,475,997
-125,582,163
-123,328,552
-120,591,845
-117,848,694
-114,659,860
-111,399,090
-107,901,392
-104,659,804
-102,049,072
-99,752,034
-99,322,453
-97,908,733
-95,983,865
-93,527,121
-91,123,107
-89,202,381
-87,225,752
-84,848,023
-82,575,151
-80,002,246
-77,783,061
-76,021,046
-74,126,619
-71,197,798
-47,852,806
-44,183,249
-41,165,798
-37,422,910
-33,570,557
-31,603,673
-29,457,033
-26,397,492
-24,240,602
-21,474,259
-29,084,474
-27,011,725
-25,829,570
-25,026,021
-24,147,835
-22,800,000
-21,600,000
-20,600,000
-20,295,944
-17,700,000
-16,400,000
-15,400,000
-14,512,234
-13,900,000
-12,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.